Importance of right communication with healthcare providers and patients about the new levothyroxine formulation: an expert opinion from Asia Pacific Thyroid Advisory Board

Author:

Razvi Salman1,Nicodemus Nemencio2,Ratnasingam Jeyakantha3,Arundhati Dasgupta4,Soh Wah Ek Abel5,Kunavisarut Tada6,Zufry Hendra7,Chaudhari Harshal8,Markova Alina9

Affiliation:

1. Clinical Research Institute, Newcastle University, Central Parkway, Newcastle upon Tyne, UK

2. Department of Medicine, University of the Philippines Manila-College of Medicine, Manila, Philippines

3. Endocrine Unit, Department of Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia

4. Department of Endocrinology, Rudraksh Superspeciality Care Hospital, Siliguri, West Bengal, India

5. Abel Soh Diabetes, Thyroid and Endocrine Clinic, Singapore

6. Division of Endocrinology & Metabolism, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand;

7. Department of Internal Medicine, Universitas Syiah Kuala/Dr Zainoel Abidin Hospital, Banda Aceh, Indonesia

8. Merck Specialities Pvt. Ltd. Vikroli (E), Mumbai, India

9. Merck Healthcare KGaA, Darmstadt, Germany

Publisher

Informa UK Limited

Reference17 articles.

1. Food and Drug Administration. FDA acts to ensure thyroid drugs don’t lose potency before expiration date; 2015 [cited 2023 Apr 2]. Available from: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-acts-ensure-thyroid-drugs-dont-lose-potency-expiration-date

2. Statista. Statista. Levothyroxine prescriptions number U.S. 2004-2020; 2023 [cited 2023 Jun 4]. Available from: https://www.statista.com/statistics/780284/levothyroxine-prescriptions-number-in-the-us/

3. Real world clinical experience with a new formulation of levothyroxine engineered to meet new and stricter regulatory requirements

4. Melmed S, Koenig R, Rosen C, et al. Williams textbook of endocrinology - 14th edition [Internet]. USA: Elsevier; 2019 [cited 2020 May 30]. Available from: https://www.elsevier.com/books/williams-textbook-of-endocrinology/melmed/978-0-323-55596-8

5. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3